Testing whether people can move properly while dosed
What they did
A University of Melbourne team designed a triple-blind study testing whether healthy volunteers can safely perform movement tasks under psilocybin doses up to 15mg, as groundwork for later work in movement disorders.
What they found
The published paper sets out the method and dosing schedule. Results from this work went on to inform a separate protocol for psilocybin-assisted physiotherapy in treatment-resistant functional neurological disorder.
Worth knowing
This is a study design paper in healthy volunteers, not a treatment trial and not a study in patients. Filed here as one to watch rather than as a finding.
Bhagavan et al. Psilocybin and Motor Function, A Triple-Blind, Dose-Finding Study in Healthy Participants. Psychiatric Research and Clinical Practice, 2024.
Read the sourceKeep reading
neurodegenerationOne woman, one dose, and weeks of speech nobody expectedbrain injuryThe case for testing psilocybin after brain injurysmokingPsilocybin beat the nicotine patch four to oneIf you found this page through a headline about Alzheimer's, start here and read the caveats before the findings. The gap between what was observed and what it means is unusually wide.
For education, not medical advice. Every write-up links back to the original source.
Nothing here is a claim that our products treat, cure or prevent any condition. Talk to a doctor before changing anything about your health.